2026 Lipoprotein Metabolism Gordon Research Conference and Gordon Research Seminar

About This Grant

ABSTRACT Abnormal lipid and lipoprotein metabolism is mechanistically linked to many common diseases such as obesity, fatty liver, diabetes, cardiovascular disease (CVD), and neurodegenerative diseases. The Gordon Research Conference (GRC) on Lipoprotein Metabolism is recognized as a premier meeting for disseminating cutting-edge research, sparking collaborations, and fostering new paradigms in this fast-moving field. The 2026 GRC will continue this tradition of highlighting research excellence in various areas of lipid and lipoprotein metabolism. The conference, to be held in Waterville Valley, NH from June 2-7, will focus on important new developments in lipid and lipoprotein metabolism relevant to human disease. Oral presentations (in 9 integrated sessions) will highlight state-of-the-art scientific approaches, exploring molecular, structural and cell biological studies, model systems of metabolism, and preclinical and human studies of new therapeutic targets. The overarching goal is to bring together scientists from diverse research areas, career stages, and geographical locations who share a passion for discovering and applying new paradigms in lipid and lipoprotein metabolism to improve human health. The GRC will be preceded by the Gordon Research Seminar (GRS), a forum for trainees to present their research in a setting of mentorship and inspiration provided by peers and selected faculty in attendance. The First Aim of the 2026 GRC on Lipoprotein Metabolism is the communication of cutting-edge, unpublished science on lipoprotein metabolism. This includes 45 presentations in 9 oral sessions, each with an identified theme and a discussion leader who will facilitate dialogue and encourage participation by all attendees. Several of the oral sessions will feature short presentations by trainees and early career investigators, selected from submitted abstracts by a panel of established investigators. The roster of confirmed speakers is an impressive array of leading researchers from a range of career stages and represent the world’s best scientists in the area of lipid and lipoprotein metabolism. Our Second Aim is to achieve broad participation and engagement opportunities for all attendees. GRCs place high priority on the principles of safety and the creation of a welcoming environment. The 2026 GRC on Lipoprotein Metabolism has long-standing reputation as a safe and engaging meeting for all participants to share their unpublished results in a collegial manner. We expect this meeting to discuss the opportunities and challenges for emerging therapies for diseases such as CVD, obesity, diabetes, fatty liver disease, and Alzheimer’s and related dementias. Collectively, we expect the 2026 Gordon Research Conference (GRC) on Lipoprotein Metabolism to improve human health through promoting open dialogue, collaboration, and scientific innovation.